Previously, it’s reported that tumor-bearing mice treated with fulvestrant exhibited enriched self-renewing CD133hi cancer stem cells, in which Notch3 and mRNA transcripts of Notch signaling pathway were elevated. This evidence concerns the gene NOTCH3 and neoplasm.